Skip to main content
. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554

Figure 1.

Figure 1

Anti-SARS-CoV-2 antibody response and duration after vaccination over time. The levels and half-lives of neutralizing antibody (A), anti-RBD total antibody (B), anti-Spike IgG (C), anti-Spike IgM (D), and anti-Spike IgA (E) were determined after vaccination over time. There were significant differences with repeated-measures ANOVA in all of antibodies (P < 0.05). The decay half-lives for individuals were estimated using a linear mixed effects model with censoring of titers below the positive threshold. Inline graphic Receive vaccine .